ArticleScientific reports2026

Computational discovery of emodin-based anthraquinones as PARP-1 inhibitors with relevance to ovarian and prostate cancer.

Sohag Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.